With a complete metabolic response rate of 82.1% after just four cycles of induction, this new regimen could change how we approach treatment for young patients with low risk, relapsed classical Hodgkin lymphoma.

According to investigators, definitive local therapy for patients with cT4 prostate cancer may improve local control and survival outcomes.

Equip yourself with comprehensive knowledge about skin cancer to better educate your patients. Learn more about its types, symptoms, risk factors, diagnosis methods, treatments, stages, complications, and prevention strategies.

This recent study suggests that systemic treatment with chemotherapy plus immunotherapy may allow patients with muscle-invasive bladder cancer (MIBC) to avoid radical cystectomy.

The ESMO Congress 2023 has highlighted how international studies in NSCLC are currently being reported at a rapid pace. This underscores the importance of staying updated on these advancements to provide optimal patient care.

Did you know that a shorter course of radiation therapy after mastectomy and breast reconstruction surgery not only provides the same protection against breast cancer recurrence but also substantially reduces life disruption and financial burden for patients?